Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II study of seliciclib in patients with previously treated advanced nasopharyngeal cancer.

Trial Profile

Phase II study of seliciclib in patients with previously treated advanced nasopharyngeal cancer.

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 11 Jun 2009

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Seliciclib (Primary)
  • Indications Nasopharyngeal cancer; Solid tumours
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Cyclacel Pharmaceuticals
  • Most Recent Events

    • 29 May 2009 Safety results from 23 patients in the lead-in part of the study have been reported at ASCO 2009. The trial will now proceed into the second part of the study; reported in a Cyclacel media release.
    • 08 Nov 2007 Recruitment is expected to start by the end of 2007.
    • 08 Feb 2007 New trial record.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top